224 related articles for article (PubMed ID: 9918543)
1. Opioid receptor selectivity of heroin given intracerebroventricularly differs in six strains of inbred mice.
Rady JJ; Elmer GI; Fujimoto JM
J Pharmacol Exp Ther; 1999 Feb; 288(2):438-45. PubMed ID: 9918543
[TBL] [Abstract][Full Text] [Related]
2. Heroin acts on different opioid receptors than morphine in Swiss Webster and ICR mice to produce antinociception.
Rady JJ; Roerig SC; Fujimoto JM
J Pharmacol Exp Ther; 1991 Feb; 256(2):448-57. PubMed ID: 1847196
[TBL] [Abstract][Full Text] [Related]
3. The heroin metabolite, 6-monoacetylmorphine, activates delta opioid receptors to produce antinociception in Swiss-Webster mice.
Rady JJ; Aksu F; Fujimoto JM
J Pharmacol Exp Ther; 1994 Mar; 268(3):1222-31. PubMed ID: 8138935
[TBL] [Abstract][Full Text] [Related]
4. Antinociceptive mechanisms of platycodin D administered intracerebroventricularly in the mouse.
Choi SS; Han EJ; Lee TH; Lee JK; Han KJ; Lee HK; Suh HW
Planta Med; 2002 Sep; 68(9):794-8. PubMed ID: 12357389
[TBL] [Abstract][Full Text] [Related]
5. Possible involvement of supraspinal opioid and GABA receptors in CDP-choline-induced antinociception in acute pain models in rats.
Hamurtekin E; Bagdas D; Gurun MS
Neurosci Lett; 2007 Jun; 420(2):116-21. PubMed ID: 17531379
[TBL] [Abstract][Full Text] [Related]
6. Nalbuphine, a mixed kappa 1 and kappa 3 analgesic in mice.
Pick CG; Paul D; Pasternak GW
J Pharmacol Exp Ther; 1992 Sep; 262(3):1044-50. PubMed ID: 1326621
[TBL] [Abstract][Full Text] [Related]
7. Supraspinal delta 2 opioid agonist analgesia in Swiss-Webster mice involves spinal GABAA receptors.
Rady JJ; Fujimoto JM
Pharmacol Biochem Behav; 1996 Jun; 54(2):363-9. PubMed ID: 8743596
[TBL] [Abstract][Full Text] [Related]
8. Functional effects of systemically administered agonists and antagonists of mu, delta, and kappa opioid receptor subtypes on body temperature in mice.
Baker AK; Meert TF
J Pharmacol Exp Ther; 2002 Sep; 302(3):1253-64. PubMed ID: 12183687
[TBL] [Abstract][Full Text] [Related]
9. Cold water swim stress- and delta-2 opioid-induced analgesia are modulated by spinal gamma-aminobutyric acidA receptors.
Killian P; Holmes BB; Takemori AE; Portoghese PS; Fujimoto JM
J Pharmacol Exp Ther; 1995 Aug; 274(2):730-4. PubMed ID: 7636735
[TBL] [Abstract][Full Text] [Related]
10. Involvement of epsilon and kappa opioid receptors in inhibition of the tail-flick response induced by bremazocine in the mouse.
Tseng LF; Collins KA
J Pharmacol Exp Ther; 1991 Oct; 259(1):330-6. PubMed ID: 1656027
[TBL] [Abstract][Full Text] [Related]
11. Morphine tolerance in mice changes response of heroin from mu to delta opioid receptors.
Rady JJ; Holmes BB; Portoghese PS; Fujimoto JM
Proc Soc Exp Biol Med; 2000 Jun; 224(2):93-101. PubMed ID: 10806416
[TBL] [Abstract][Full Text] [Related]
12. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
Wells JL; Bartlett JL; Ananthan S; Bilsky EJ
J Pharmacol Exp Ther; 2001 May; 297(2):597-605. PubMed ID: 11303048
[TBL] [Abstract][Full Text] [Related]
13. Antagonism of delta(2)-opioid receptors by naltrindole-5'-isothiocyanate attenuates heroin self-administration but not antinociception in rats.
Martin TJ; Kim SA; Cannon DG; Sizemore GM; Bian D; Porreca F; Smith JE
J Pharmacol Exp Ther; 2000 Sep; 294(3):975-82. PubMed ID: 10945849
[TBL] [Abstract][Full Text] [Related]
14. Mu but not delta and kappa opioid receptor involvement in ventrolateral orbital cortex opioid-evoked antinociception in formalin test rats.
Xie YF; Wang J; Huo FQ; Jia H; Tang JS
Neuroscience; 2004; 126(3):717-26. PubMed ID: 15183520
[TBL] [Abstract][Full Text] [Related]
15. Buprenorphine blocks epsilon- and micro-opioid receptor-mediated antinociception in the mouse.
Mizoguchi H; Spaulding A; Leitermann R; Wu HE; Nagase H; Tseng LF
J Pharmacol Exp Ther; 2003 Jul; 306(1):394-400. PubMed ID: 12721333
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological characterization of the ameliorating effect on short-term memory impairment and antinociceptive effect of KT-90 in mice.
Hiramatsu M; Hoshino T; Kanematsu K
Behav Brain Res; 2005 May; 160(2):374-81. PubMed ID: 15863234
[TBL] [Abstract][Full Text] [Related]
17. Endogenous opioids released by suspending mice by the tail selectively enhance spinal mu opioid analgesia.
Smith FL; Brase DA; Dombrowski DS; Dewey WL
J Pharmacol Exp Ther; 1994 Sep; 270(3):1177-85. PubMed ID: 7932169
[TBL] [Abstract][Full Text] [Related]
18. dextro- and levo-morphine attenuate opioid delta and kappa receptor agonist produced analgesia in mu-opioid receptor knockout mice.
Wu HE; Sun HS; Terashivili M; Schwasinger E; Sora I; Hall FS; Uhl GR; Tseng LF
Eur J Pharmacol; 2006 Feb; 531(1-3):103-7. PubMed ID: 16445907
[TBL] [Abstract][Full Text] [Related]
19. Independent expression of two pharmacologically distinct supraspinal mu analgesic systems in genetically different mouse strains.
Pick CG; Nejat RJ; Pasternak GW
J Pharmacol Exp Ther; 1993 Apr; 265(1):166-71. PubMed ID: 8386234
[TBL] [Abstract][Full Text] [Related]
20. Enhancement mu opioid antinociception by oral delta9-tetrahydrocannabinol: dose-response analysis and receptor identification.
Cichewicz DL; Martin ZL; Smith FL; Welch SP
J Pharmacol Exp Ther; 1999 May; 289(2):859-67. PubMed ID: 10215664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
